STAT
NOVEMBER 19, 2024
patent expires in 2028. Although more pharmaceutical companies are tailoring their business models to focus on low-income countries, overall industry efforts remain limited and patient access continues to suffer as a result , STAT writes, citing a new analysis.
European Pharmaceutical Review
OCTOBER 24, 2023
Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2028, according to a report by Arizton. billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent up to 2028. percent in 2022.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JULY 29, 2024
Thomas Schinecker, chief executive of the pharmaceutical company, said its first obesity drugs would come to market “significantly faster than people are expecting,” potentially by 2028. The treatments, acquired in a $3.1 reduction in weight compared with a placebo after four weeks.
European Pharmaceutical Review
DECEMBER 4, 2023
A report published by MarketsandMarkets has estimated that the pharmaceutical excipients market will value $14.9 billion by 2028, growing at a CAGR of 6.8 percent between 2023 to 2028. This is compared to the expected revenue for the market in 2023 reaching $10.7
Express Pharma
MAY 30, 2024
According to GlobalData’s Pharmaceutical Intelligence Center, for instance, the number of diagnosed prevalent cases of Alzheimer’s disease (excluding mild cognitive impairment) across major markets in APAC (Australia, China, India, Japan, South Korea) is expected to increase at an average annual growth rate (AGR) of 4.54 per cent from 7.45
pharmaphorum
JANUARY 5, 2023
Recruiting and retaining talent is one of the biggest challenges facing the industry now through 2028, as the US Bureau of Labor Statistics expects life, physical, and social sciences to grow 7%. Paired with the current US pharmaceutical job vacancy rate of around 8%, companies will need to pivot to fill the incredible labour needs.
European Pharmaceutical Review
OCTOBER 12, 2023
Sustainability in pharmaceutical manufacturing AstraZeneca – biomethane supply AstraZeneca will establish the first industrial-scale supply of biomethane” In mid-September, a 15-year partnership between AstraZeneca and Future Biogas was agreed. Subject to planning permission, the site is expected to be opened by 2028.
Expert insights. Personalized for you.
278 
Let's personalize your content